1980
DOI: 10.1093/nar/8.23.5767
|View full text |Cite
|
Sign up to set email alerts
|

The translocation inhibitor tuberactinomycin binds to nucleic acids and blocks the in vitro assembly of 50S subunits

Abstract: Binding studies were performed with a [14C]-labelled derivative of viomycin, tuberactinomycin 0 (TUM O). TUM O bound to 30S and 50S subunits. The binding component was the RNA, since ribosomal proteins did not bind the drug. Other RNAs such as tRNA, phage RNA (MS2), and homopolynucleotides also bound the drug. Striking differences in the binding capacity of the various homopolynucleotides were found. Poly(U) bound strongly, poly(G) and poly(C) bound intermediately, whereas poly(A) showed a very low binding. DN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
2
1

Year Published

1985
1985
2010
2010

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 18 publications
2
2
1
Order By: Relevance
“…Here, two speculative conclusions can be made. First, the nearly complete inhibition of translocation observed at both high viomycin and neomycin concentrations, where previous data17,35,41 and our titration experiments argue multiple drug molecules may be bound, suggests that primary and secondary binding site occupancy may operate additively with respect to tRNA dynamics but synergistically on the extent of translocation inhibition. Second, the binding of antibiotics outside of the h44 decoding site, which have the net effect of stabilizing hybridstate tRNA configurations, may exhibit more pronounced translocation inhibition.…”
Section: Resultssupporting
confidence: 52%
“…Here, two speculative conclusions can be made. First, the nearly complete inhibition of translocation observed at both high viomycin and neomycin concentrations, where previous data17,35,41 and our titration experiments argue multiple drug molecules may be bound, suggests that primary and secondary binding site occupancy may operate additively with respect to tRNA dynamics but synergistically on the extent of translocation inhibition. Second, the binding of antibiotics outside of the h44 decoding site, which have the net effect of stabilizing hybridstate tRNA configurations, may exhibit more pronounced translocation inhibition.…”
Section: Resultssupporting
confidence: 52%
“…Here, two speculative conclusions can be made. First, the nearly complete inhibition of translocation observed at both high viomycin and neomycin concentrations, where previous data 17,35,41 and our titration experiments argue multiple drug molecules may be bound, suggests that primary and secondary binding site occupancy may operate additively with respect to tRNA dynamics but synergistically on the extent of translocation inhibition. Second, the binding of antibiotics outside of the h44 decoding site, which have the net effect of stabilizing hybrid-state tRNA configurations, may exhibit more pronounced translocation inhibition.…”
Section: Resultssupporting
confidence: 52%
“…The relatively low binding of tuberactinomycin to nucleic acids observed here is due to the higher ionic strength we applied in these equilibrium dialysis experiments in contrast to the previous data [12]. Increasing the ionic strength Maximal stimulation of the binding of tuberactinomycin to programmed ribosomes was achieved by the addition of a two-molar excess of tRNAPhe (375 pmol tRNAPhe, see table 1).…”
Section: Resultscontrasting
confidence: 53%